Never In Mitosis Gene A (NIMA)-related kinase 4 (NEK4), a serine/threonine protein kinase, is involved in several cellular processes, including the DNA damage response and mRNA splicing, and we identified it as a potential new drug target in triple-negative breast cancer. The gene discussed is NEK1; the disease is triple-negative breast carcinoma.